Dr. Soe Tin Maunglay, MD

Dr. Maunglay practices at Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare.

Dr. Maunglay's NPI, 1093864373, was assigned on January 9, 2007. Dr. Maunglay graduated from Marmara Univ- Fac Med in 2000. Dr. Maunglay holds California license C152411.

Dr. Maunglay's primary practice is Desert Regional Medical Center, at 1150 North Indian Canyon Drive, Palm Springs, CA 92262 in Riverside County. The practice phone is (760) 323-6511.

Dr. Maunglay's primary practice is Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare. Dr. Maunglay is also affiliated with Eisenhower Health. Dmand AI also links Dr. Maunglay to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maunglay practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Maunglay's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Maunglay is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Maunglay's licenses on file in 8 states: California, Florida, Michigan, Connecticut, Alabama, New York, Ohio and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Maunglay treats.

CMS data shows 813 Medicare services from Dr. Maunglay across 3 procedure codes in 2024, all of them office visits, for 157 Medicare patients. Medicare paid $56,935 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Maunglay in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maunglay's median patient age at 61, with 57% women.

In 2024, Dr. Maunglay wrote 504 Medicare Part D claims for 81 patients. 75% of them were for generic drugs. CMS names the drug for 313 of them, across 17 drugs with 11 or more claims each, at $584,628 in total drug cost. In 2023, CMS named 326 claims across 18 drugs.

Dr. Maunglay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 150 general payments to Dr. Maunglay from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Amgen Inc. paid the most, $1,292.

Dr. Maunglay graduated from Marmara Univ- Fac Med in 2000.

Dr. Maunglay is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.